Rotenone-induced apoptosis is mediated by p38 and JNK MAP kinases in human dopaminergic SH-SY5Y cells.
D017209:Apoptosis / Q000187:drug effects*; D020169:Caspases / Q000009:adverse effects / Q000187:drug effects / Q000378:metabolism; D045744:Cell Line, Tumor; D004390:Chlorpyrifos / Q000633:toxicity; D006801:Humans; D048031:JNK Mitogen-Activated Protein Kinases / Q000009:adverse effects / Q000187:drug effects / Q000378:metabolism; D048670:MAP Kinase Kinase 4; D020929:Mitogen-Activated Protein Kinase Kinases / Q000009:adverse effects / Q000187:drug effects / Q000378:metabolism; D011954:Receptors, Dopamine / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D012402:Rotenone / Q000737:chemistry / Q000633:toxicity*; D015398:Signal Transduction / Q000187:drug effects; D014162:Transfection / Q000379:methods; D048051:p38 Mitogen-Activated Protein Kinases / Q000009:adverse effects* / Q000187:drug effects / Q000378:metabolism
D011954:Receptors, Dopamine; D012402:Rotenone; D048031:JNK Mitogen-Activated Protein Kinases; D048051:p38 Mitogen-Activated Protein Kinases; D048670:MAP Kinase Kinase 4; D020929:Mitogen-Activated Protein Kinase Kinases; D020169:Caspases; D004390:Chlorpyrifos